Research ArticleClinical Studies
Open Access

Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World

AKINORI MINATO, RIEKO KIMURO, DAICHI OHNO, KENTAROU TANIGAWA, KEISUKE KURETAKE, TAKUO MATSUKAWA, TOMOHISA TAKABA, KAZUMASA JOJIMA, MIRII HARADA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA, NAOHIRO FUJIMOTO and HIROSHI MIYAMOTO
Anticancer Research September 2023, 43 (9) 4055-4060; DOI: https://doi.org/10.21873/anticanres.16594

Article Information

vol. 43 no. 9 4055-4060
DOI 
https://doi.org/10.21873/anticanres.16594
PubMed 
37648337
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 31, 2023
  • Revision received June 28, 2023
  • Accepted June 29, 2023
  • Published online August 30, 2023.
Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. AKINORI MINATO1⇑,
  2. RIEKO KIMURO1,
  3. DAICHI OHNO1,
  4. KENTAROU TANIGAWA1,
  5. KEISUKE KURETAKE1,
  6. TAKUO MATSUKAWA1,
  7. TOMOHISA TAKABA1,
  8. KAZUMASA JOJIMA1,
  9. MIRII HARADA1,
  10. KATSUYOSHI HIGASHIJIMA1,
  11. YUJIRO NAGATA1,
  12. IKKO TOMISAKI1,
  13. KENICHI HARADA1,
  14. NAOHIRO FUJIMOTO1 and
  15. HIROSHI MIYAMOTO2
  1. 1Department of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan;
  2. 2Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, U.S.A.
  1. Correspondence to: Akinori Minato, MD, Ph.D., Department of Urology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan. E-mail: a-minato{at}med.uoeh-u.ac.jp
View Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World
AKINORI MINATO, RIEKO KIMURO, DAICHI OHNO, KENTAROU TANIGAWA, KEISUKE KURETAKE, TAKUO MATSUKAWA, TOMOHISA TAKABA, KAZUMASA JOJIMA, MIRII HARADA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA, NAOHIRO FUJIMOTO, HIROSHI MIYAMOTO
Anticancer Research Sep 2023, 43 (9) 4055-4060; DOI: 10.21873/anticanres.16594
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords